Vitality Vision

This episode opens with a celebration—Voloridge was named the Best Midsize Business to Work For in South Florida by the Sun Sentinel—and quickly shifts into one of the most impactful conversations yet. Greg, Barry, and David break down two of the most powerful (and misunderstood) markers of long-term health: A1C and ApoE protein. First, David unpacks the science behind A1C—a marker of long-term blood sugar regulation—and explains why it’s consistently showing up across our models as a strong predictor of disease. The team explores why even fit individuals can have high A1C, how it differs from insulin and glucose, and what actions can actually help lower it. Then, they turn to ApoE protein, a rising star in the world of cognitive health prediction. While many people know the ApoE gene, David explains why the protein may be even more valuable for early detection of cognitive decline—and how it connects to future offerings in the Volo platform. In this episode: What A1C really measures—and why it matters for metabolic and cardiac health How diet, exercise, CGMs, and stress affect A1C—and how to act on it Why the ApoE protein is showing promise beyond genetic testing The difference between genetics, epigenetics, and proteomics How we’re building tools to make this kind of insight available to everyone The conversation wraps with another round of underrated or overrated, where Greg, David, and Barry weigh in on everything from zone 2 cardio to CGMs and AI health coaches. This is a clear, candid, and deeply useful look at how data science is redefining what we can know—and what we can do—about our health.

In Episode 5 of Vitality Vision by Volo, we take a deep dive into one of the most overlooked but powerful health indicators: Cystatin C. Greg Bennett, Barry Miller, and David Vogel unpack what this biomarker is, why it matters, and how it compares to more traditional markers like creatinine when assessing kidney function and overall health risk.We explore how Cystatin C plays a critical role in the predictive models behind our proprietary Volo Health Scores, and how early changes in this marker can provide insight into longevity, metabolic health, and even cardiovascular risk—often well before symptoms appear.David walks us through the science, Barry shares real-world business implications, and Greg provides perspective from decades of elite-level sport and performance.We also update listeners on our journey building Voloridge Health—what’s new with the Volo App, what’s happening inside the Volo Club, and how our team is working to empower people with clarity, ownership, and action when it comes to their health.This episode is essential listening for anyone who wants to understand what’s really going on inside their body—and why standard lab panels might not be telling the full story.  Try out our Volo Simulator and explore our Blood Biomarker Reference Guide for free at https://voloridge.health/.Share your thoughts and questions with us at podcast@voloridgehealth.com.

"The ability to measure and assess health before decline occurs will be the greatest revolution of our time." – Fitness Insider Most people don’t think about their health until something goes wrong. In this episode of Vitality Vision by Volo, we discuss how we’re building the tools to change that—by making health as measurable and actionable as wealth. What’s broken in healthcare today? Why our models are 6x more accurate than traditional risk calculators How Volo Health Scores can help people take control of their health How we build a world-class data science team for health. Try out our Volo Simulator and explore our Blood Biomarker Reference Guide for free at https://voloridge.health/. Share your thoughts and questions with us at podcast@voloridgehealth.com.

Discover how data science is revolutionizing health measurements and predictions. Traditional health markers like LDL may mislead, while innovative modeling enhances disease risk assessments. Learn why doctor-derived insights can differ dramatically from data-driven ones. The conversation also highlights the importance of balancing longevity with quality of life. Dive into the complexities of predictive models, bias reduction, and the collaborative efforts in health research that pave the way for proactive approaches to well-being.

Join David Vogel, CEO of Voloridge Investment Management, and Barry Miller, President of Voloridge Health, as they dive deep into the pivotal role of exercise in longevity. They discuss whether exercise is the key to a long life, emphasizing the balance between strength training, cardio, and hybrid workouts. The duo also explores the transformative power of technology in personal health tracking and how innovative health metrics can empower individuals. Don’t miss their insights on the common pitfalls in training for longevity and the impact of personalized health assessments!

Welcome to Vitality Vision by Volo, where we’re redefining how health is measured and optimized. In this first episode, Greg Bennett, Barry Miller, and David Vogel introduce who we are, why we’re building Voloridge Health, and what makes our approach to health different. We discuss the shift from reactive to proactive health, what the future of longevity looks like, and why data science is the key to better health insights.Who we are & why we started Voloridge HealthThe biggest gaps in healthcare todayWhy data-driven health insights are the futureWhat listeners can expect from future episodesTry out our Volo Simulator and explore our Blood Biomarker Reference Guide for free at https://voloridge.health/.Share your thoughts and questions with us at podcast@voloridgehealth.com.